On the recordJanuary 17, 2017
I wish to address a troubling report about the President-elect's nominee for Secretary of Health and Human Services that came out last night. We learned that Congressman Price bought shares in a medical device manufacturing company just days before introducing legislation in the House that would directly benefit that company. His legislation wasn't broad legislation. It didn't affect health care in general. It specifically blocked a regulation on medical device companies that do hip and knee implants, including the very business he bought stock in. According to CNN, the company Representative Price bought stock in was one of two companies that would have been hardest hit by this new regulation--one of two--and he puts in legislation to repeal it just after buying stock in it. Again, this is not someone who has Johnson & Johnson stock and then votes to cut Medicare. This is a narrow company that works on hip and knee implants--narrow legislation that deals with undoing some regulations on them. It is really troubling. These revelations come on top of the report late last year by CQ and the Wall Street Journal that Congressman Price had traded stocks in dozens of health care companies valued at hundreds of thousands of dollars during his time in the House as chair on the Budget Committee, when he introduced, sponsored, or cosponsored several pieces of legislation that impacted these companies.…





